DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 26, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.

The entire rule text may be found here:  https://www.federalregister.gov/articles/2014/08/22/2014-19922/schedules-of-controlled-substances-rescheduling-of-hydrocodone-combination-products-from-schedule

Frequently Asked Questions regarding this change may be found here: Hydrocodone FAQs



More Latest News

Opioid Epidemic in Florida
April 17, 2018

In an effort to combat the national opioid epidemic in Florida, in March 2018 Governor Rick Scott signed HB 21 creating new limits on schedule II prescriptions for pain medication. Continue reading


New Legislation Impacting Your Profession
April 17, 2018

Click here to view a full list of bill summaries from the 2018 Florida Legislative Session that may impact your profession. Continue reading